CoChat

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Open access
Zewinger, Stephen, Kleber, Marcus E, Tragante, Vinicius, McCubrey, Raymond O, Schmidt, Amand F, Direk, Kenan, Laufs, Ulrich, Werner, Christian, Koenig, Wolfgang, Rothenbacher, Dietrich, Mons, Ute, Breitling, Lutz P, Brenner, Herrmann, Jennings, Richard T, Petrakis, Ioannis, Triem, Sarah, Klug, Mira, Filips, Alexandra, Blankenberg, Stefan, Waldeyer, Christoph, Sinning, Christoph, Schnabel, Renate B, Lackner, Karl J, Vlachopoulou, Efthymia, Nygård, Ottar, Svingen, Gard Frodahl Tveitevåg, Pedersen, Eva Ringdal, Tell, Grethe S, Sinisalo, Juha, Nieminen, Markku S, Laaksonen, Reijo, Trompet, Stella, Smit, Roelof A J, Sattar, Naveed, Jukema, J Wouter, Groesdonk, Heinrich V, Delgado, Graciela, Stojakovic, Tatjana, Pilbrow, Anna P, Cameron, Vicky A, Richards, A Mark, Doughty, Robert N, Gong, Yan, Cooper-DeHoff, Rhonda, Johnson, Julie, Scholz, Markus, Beutner, Frank, Thiery, Joachim, Smith, J Gustav, Vilmundarson, Ragnar O, McPherson, Ruth, Stewart, Alexandre F R, Cresci, Sharon, Lenzini, Petra A, Spertus, John A, Olivieri, Oliviero, Girelli, Domenico, Martinelli, Nicola I, Leiherer, Andreas, Saely, Christoph H, Drexel, Heinz, Mündlein, Axel, Braund, Peter S, Nelson, Christopher P, Samani, Nilesh J, Kofink, Daniel, Hoefer, Imo E, Pasterkamp, Gerard, Quyyumi, Arshed A, Ko, Yi-An, Hartiala, Jaana A, Allayee, Hooman, Tang, W H Wilson, Hazen, Stanley L, Eriksson, Niclas, Held, Claes, Hagström, Emil, Wallentin, Lars, Åkerblom, Axel, Siegbahn, Agneta, Karp, Igor, Labos, Christopher, Pilote, Louise, Engert, James C, Brophy, James M, Thanassoulis, George, Bogaty, Peter, Szczeklik, Wojciech, Kaczor, Marcin, Sanak, Marek, Virani, Salim S, Ballantyne, Christie M, Lee, Vei-Vei, Boerwinkle, Eric, Holmes, Michael V, Horne, Benjamin D, Hingorani, Aroon, Asselbergs, Folkert W, Patel, Riyaz S, Krämer, Bernhard K, Scharnagl, Hubert, Fliser, Danilo, März, Winfried, Speer, Thimoteus · 2017 · The Lancet Diabetes & Endocrinology
Cited by 101

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Summary Background Lipoprotein(a) concentrations in plasma are associated with cardiovascular risk in the general population. Whether lipoprotein(a) concentrations or LPA genetic variants predict long-term mortality in patients with established coronary heart disease remains less clear. Methods We obtained data from 3313 patients with established coronary heart disease in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. We tested associations of tertiles of lipoprotein(a) concentration in plasma and two LPA single-nucleotide polymorphisms ([SNPs] rs10455872 and rs3798220) with all-cause mortality and cardiovascular mortality by Cox regression analysis and with severity of disease by generalised linear modelling, with and without adjustment for age, sex, diabetes diagnosis, systolic blood pressure, BMI, smoking status, estimated glomerular filtration rate, LDL-cholesterol concentration, and use of lipid-lowering therapy. Results for plasma lipoprotein(a) concentrations were validated in five independent studies involving 10 195 patients with established coronary heart disease. Results for genetic associations were replicated through large-scale collaborative analysis in the GENIUS-CHD consortium, comprising 106 353 patients with established coronary heart disease and 19 332 deaths in 22 studies or cohorts. Findings The median follow-up was 9·9 years. Increased severity of coronary heart disease was associated with lipoprotein(a) concentrations in plasma in the highest tertile (adjusted hazard radio [HR] 1·44, 95% CI 1·14–1·83) and the presence of either LPA SNP (1·88, 1·40–2·53). No associations were found in LURIC with all-cause mortality (highest tertile of lipoprotein(a) concentration in plasma 0·95, 0·81–1·11 and either LPA SNP 1·10, 0·92–1·31) or cardiovascular mortality (0·99, 0·81–1·2 and 1·13, 0·90–1·40, respectively) or in the validation studies. Interpretation In patients with prevalent coronary heart disease, lipoprotein(a) concentrations and genetic variants showed no associations with mortality. We conclude that these variables are not useful risk factors to measure to predict progression to death after coronary heart disease is established. Funding Seventh Framework Programme for Research and Technical Development (AtheroRemo and RiskyCAD), INTERREG IV Oberrhein Programme, Deutsche Nierenstiftung, Else-Kroener Fresenius Foundation, Deutsche Stiftung für Herzforschung, Deutsche Forschungsgemeinschaft, Saarland University, German Federal Ministry of Education and Research, Willy Robert Pitzer Foundation, and Waldburg-Zeil Clinics Isny.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(17)30096-7

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 101

Metadata

Authors
Zewinger, S., Kleber, M. E., Tragante, V., McCubrey, R. O., Schmidt, A. F., Direk, K., Laufs, U., Werner, C., Koenig, W., Rothenbacher, D., Mons, U., Breitling, L. P., Brenner, H., Jennings, R. T., Petrakis, I., Triem, S., Klug, M., Filips, A., Blankenberg, S., Waldeyer, C., Sinning, C., Schnabel, R. B., Lackner, K. J., Vlachopoulou, E., Nygård, O., Svingen, G. F. T., Pedersen, E. R., Tell, G. S., Sinisalo, J., Nieminen, M. S., Laaksonen, R., Trompet, S., Smit, R. A. J., Sattar, N., Jukema, J. W., Groesdonk, H. V., Delgado, G., Stojakovic, T., Pilbrow, A. P., Cameron, V. A., Richards, A. M., Doughty, R. N., Gong, Y., Cooper-DeHoff, R., Johnson, J., Scholz, M., Beutner, F., Thiery, J., Smith, J. G., Vilmundarson, R. O., McPherson, R., Stewart, A. F. R., Cresci, S., Lenzini, P. A., Spertus, J. A., Olivieri, O., Girelli, D., Martinelli, N. I., Leiherer, A., Saely, C. H., Drexel, H., Mündlein, A., Braund, P. S., Nelson, C. P., Samani, N. J., Kofink, D., Hoefer, I. E., Pasterkamp, G., Quyyumi, A. A., Ko, Y.-A., Hartiala, J. A., Allayee, H., Tang, W. H. W., Hazen, S. L., Eriksson, N., Held, C., Hagström, E., Wallentin, L., Åkerblom, A., Siegbahn, A., Karp, I., Labos, C., Pilote, L., Engert, J. C., Brophy, J. M., Thanassoulis, G., Bogaty, P., Szczeklik, W., Kaczor, M., Sanak, M., Virani, S. S., Ballantyne, C. M., Lee, V.-V., Boerwinkle, E., Holmes, M. V., Horne, B. D., Hingorani, A., Asselbergs, F. W., Patel, R. S., Krämer, B. K., Scharnagl, H., Fliser, D., März, W., & Speer, T.
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2017-07
Volume
5
Issue
7
Pages
534-543
ISSN
2213-8587 (ISSN-L)
OpenAlex
W2618542302
Cited by
101
References
7
FWCI
14.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. https://app.cochat.ai/papers/10.1016/s2213-8587(17)30096-7
The paper
Zewinger, S., Kleber, M. E., Tragante, V., McCubrey, R. O., Schmidt, A. F., Direk, K., Laufs, U., Werner, C., Koenig, W., Rothenbacher, D., Mons, U., Breitling, L. P., Brenner, H., Jennings, R. T., Petrakis, I., Triem, S., Klug, M., Filips, A., Blankenberg, S., . . . Speer, T. (2017). Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(17)30096-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.